Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant factor VIIa modified with three terminal repeats derived from the β chain of human chorionic gonadotropin

EU orphan designation number: EU/3/14/1319   
Active ingredient: Recombinant factor VIIa modified with three terminal repeats derived from the β chain of human chorionic gonadotropin
Indication: Treatment of haemophilia B
Sponsor: Richardson Associates Regulatory Affairs Ltd
Tripps Farmhouse, Lower End, Great Milton, Oxfordshire OX44 7NJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/08/2014 Orphan designation EMA/OD/073/14 (2014)6125 of 22/08/2014